Unknown

Dataset Information

0

Systematic review protocol on Bacillus Calmette-Guerin (BCG) revaccination and protection against tuberculosis.


ABSTRACT: INTRODUCTION:Tuberculosis (TB) is a disease caused by Mycobacterium tuberculosis (M.TB) and other species of the Mycobacterium tuberculosis complex. Globally, TB is ranked as the ninth leading cause of death and the leading cause of death from a single infectious agent. The bacille Calmette-Guerin (BCG) vaccine has been used globally since 1921 for the prevention of TB in humans, and was derived from an attenuated strain of Mycobacterium bovis. Evidence from previous randomised trials show that the efficacy of primary BCG vaccination against pulmonary TB ranged from no protection to very high protection. In addition, some studies suggest a benefit of BCG revaccination. For example, a recent trial conducted in South Africa showed that BCG revaccination of adolescents could reduce the risk of TB infection by half. However, we are not aware of any recent systematic reviews of the effects of BCG revaccination. Thus, the need for this systematic review of the effects of BCG revaccination on protection against TB infection and disease. METHOD AND ANALYSIS:We will search PubMed, the Cochrane Central Register of Controlled Trials, EMBASE, WHO International Clinical Trials Registry Platform and reference lists of relevant publications for potentially eligible studies. We will screen search outputs, select eligible studies, extract data and assess risk of bias in duplicate. Discrepancies will be resolved by discussion and consensus or arbitration. We will use the Grading of Recommendations Assessment, Development and Evaluation method to assess the certainty of the evidence. The planned systematic review was registered with the International Prospective Register of Systematic Reviews (PROSPERO) in August 2018. ETHICS AND DISSEMINATION:Publicly available data will be used, hence no formal ethical approval will be required for this review. The findings of the review will be disseminated through conference presentations and publication in an open-access peer-reviewed journal. PROSPERO REGISTRATION NUMBER:CRD42018105916.

SUBMITTER: Mahasha PW 

PROVIDER: S-EPMC6797475 | biostudies-literature | 2019 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Systematic review protocol on Bacillus Calmette-Guerin (BCG) revaccination and protection against tuberculosis.

Mahasha Phetole Walter PW   Ndwandwe Duduzile Edith DE   Mavundza Edison Johannes EJ   Shey Muki M   Wiysonge Charles Shey CS  

BMJ open 20191015 10


<h4>Introduction</h4>Tuberculosis (TB) is a disease caused by <i>Mycobacterium tuberculosis</i> (M.TB) and other species of the Mycobacterium tuberculosis complex. Globally, TB is ranked as the ninth leading cause of death and the leading cause of death from a single infectious agent. The bacille Calmette-Guerin (BCG) vaccine has been used globally since 1921 for the prevention of TB in humans, and was derived from an attenuated strain of <i>Mycobacterium bovis</i>. Evidence from previous random  ...[more]

Similar Datasets

| S-EPMC7921379 | biostudies-literature
| S-EPMC4792288 | biostudies-literature
| S-EPMC7025668 | biostudies-literature
| S-EPMC1891101 | biostudies-literature